Skip to main content
Journal cover image

Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial

Publication ,  Journal Article
Lincoff, AM; Tcheng, JE; Califf, RM; Cabot, CF; Miller, DP; Booth, JE; Montague, EA; Anderson, KM; Topol, EJ
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
February 1, 1997

Duke Scholars

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

February 1, 1997

Volume

29

Issue

2

Start / End Page

7396 / 7396

Publisher

ELSEVIER SCIENCE INC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lincoff, A. M., Tcheng, J. E., Califf, R. M., Cabot, C. F., Miller, D. P., Booth, J. E., … Topol, E. J. (1997). Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29(2), 7396–7396.
Lincoff, A. M., J. E. Tcheng, R. M. Califf, C. F. Cabot, D. P. Miller, J. E. Booth, E. A. Montague, K. M. Anderson, and E. J. Topol. “Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1, 1997): 7396–7396.
Lincoff AM, Tcheng JE, Califf RM, Cabot CF, Miller DP, Booth JE, et al. Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb 1;29(2):7396–7396.
Lincoff, A. M., et al. “Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 29, no. 2, ELSEVIER SCIENCE INC, Feb. 1997, pp. 7396–7396.
Lincoff AM, Tcheng JE, Califf RM, Cabot CF, Miller DP, Booth JE, Montague EA, Anderson KM, Topol EJ. Abciximab (c7E3 fab, ReoPro) with reduced heparin dosing during coronary intervention: Final results of the EPILOG trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 1997 Feb 1;29(2):7396–7396.
Journal cover image

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

February 1, 1997

Volume

29

Issue

2

Start / End Page

7396 / 7396

Publisher

ELSEVIER SCIENCE INC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology